Let the Best Drug Win with Errik Anderson
<p>Alloy has rapidly grown into a thriving ecosystem empowering the global scientific community. The company’s innovative business model is centered on 3 pillars: platforms, services, and company creation. Alloy develops technologies such as its <a href="https://alloytx.com/antibodies/" rel="noopener ugc nofollow" target="_blank">ATX-Gx</a> humanized transgenic mice antibody discovery platform and makes them available to partners through non-exclusive, affordable licensing. This allows even academic labs and small biotechs to use powerful tools previously only accessible to large pharmas. Alloy also provides tailored drug discovery services, running campaigns for clients seeking to outsource highly specialized work. Anderson embraces the “service mentality” as it generates revenue to improve Alloy’s platforms, while solving problems for partners.</p>
<p><a href="https://medium.com/@axialxyz/let-the-best-drug-win-with-errik-anderson-e11f6b452fbc"><strong>Learn More</strong></a></p>